TROP2 (trophoblast cell surface antigen-2) is a transmembrane glycoprotein member of the EpCAM family, overexpressed in many tumours (e.g., breast cancer and NSCLC), acting either like an oncogene driver or an onco-suppressor. Here, TACSTD2 is linked to neoplasm.